Does the Macrophage Migration Inhibitory Factor in Ascites in patients with ovarian carcinoma effects the prognosis of ovarian carcinoma?

被引：0
|
作者：
Krockenberger, M. [1 ]
Haeusler, S. [1 ]
Engel, J. B. [1 ]
Dietl, J. [1 ]
Hoenig, A. [1 ]
机构：
[1] Univ Frauenklin Wurzburg, Wurzburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2009年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [1] Macrophage Migration-inhibitory Factor Levels in Serum of Patients with Ovarian Cancer Correlates with Poor Prognosis
    Krockenberger, Mathias
    Kranke, Peter
    Haeusler, Sebastian
    Engel, Joerg Bernhard
    Horn, Evi
    Nuernberger, Katharina
    Wischhusen, Joerg
    Dietl, Johannes
    Hoenig, Arnd
    ANTICANCER RESEARCH, 2012, 32 (12) : 5233 - 5238
  • [2] Macrophage migration inhibitory factor expression in ovarian cancer
    Agarwal, Rinki
    Whang, Dong Hee
    Alvero, Ayesha B.
    Visintin, Irene
    Lai, Yinglei
    Segal, Elliot A.
    Schwartz, Peter
    Ward, David
    Rutherford, Thomas
    Mor, Gil
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (04) : 348.e1 - 348.e5
  • [3] Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma
    Zhao, Yi-Ming
    Wang, Lu
    Dai, Zhi
    Wang, Dan-Dan
    Hei, Zhen-Yu
    Zhang, Ning
    Fu, Xiu-Tao
    Wang, Xi-Long
    Zhang, Shun-Cai
    Qin, Lun-Xiu
    Tang, Zhao-You
    Zhou, Jian
    Fan, Jia
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (10) : 2463 - 2472
  • [4] PROGNOSIS IN OVARIAN CARCINOMA
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1966, 2 (5508): : 286 - +
  • [5] Expression of macrophage migration inhibitory factor in hepatocellular carcinoma
    Yu, Xiao-Hui
    Wu, Xiong-Zhi
    Guan, Quan-Lin
    Zhao, Lian-San
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A167 - A168
  • [6] Correlations of leukemia inhibitory factor and macrophage migration inhibitory factor with endometrial carcinoma
    Xiao, W.
    Jin, O.
    Han, S.
    Nie, R.
    Zhu, L.
    Gao, X.
    Li, L.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (02) : 146 - 149
  • [7] Macrophage migration inhibitory factor (MIF) from serum and ascites of ovarial carcinoma patients inhibits the antitumoral Immune response
    Krockenberger, M.
    Engel, J. B.
    Haeusler, S.
    Wischhusen, J.
    Dietl, J.
    Hoenig, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (05) : 540 - 540
  • [8] MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS IN SERUM OF OVARIAN CANCER PATIENTS CORRELATE WITH POOR PROGNOSTIC PARAMETERS IN OVARIAN CANCER
    Krockenberger, M.
    Engel, J.
    Haeusler, S.
    Wischhusen, J.
    Heuer, St.
    Dietl, J.
    Hoenig, A.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1987 - 1988
  • [9] Macrophage colony-stimulating factor as a marker of ovarian carcinoma
    Ookura, N
    Nishimura, H
    Kiyozuka, Y
    Komai, K
    Ushijima, K
    Sugiyama, T
    Nishida, T
    Yakushiji, M
    ONCOLOGY REPORTS, 1997, 4 (05) : 967 - 971
  • [10] Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma
    de Souza, Mariana Barbosa
    Curioni, Otavio Alberto
    Kanda, Jossi Ledo
    De Carvalho, Marcos Brasilino
    ONCOLOGY LETTERS, 2014, 8 (05) : 2267 - 2275
12345